62nd ASH Annual Meeting and Exposition

At Thermo Fisher Scientific, we have developed leading next-generation sequencing (NGS) solutions to address key challenges in molecular profiling for hematological samples.

Now labs can simultaneously profile a large number of genetic targets across multiple samples and get results in as fast as a single day.

Join us during the 62nd ASH Annual Meeting and Exposition to learn how we can help simplify your journey to answers in assessing myeloid and lymphoid malignancy samples.

Gene Graphic_final_croped

Sign up here to receive a copy of our presentations after the event has concluded.

Educational Opportunities

Product Theatre

NGS solutions that help simplify your journey to answers in hemato-oncology research

December 5, 2020

Amy Carroll, PhD

Director, North America Medical Affairs, NGS and Oncology

Thermo Fisher Scientific

This workshop will highlight our latest NGS solutions for hemato-oncology research testing. See the Oncomine Myeloid Assay GX on the revolutionary Ion Torrent Genexus System, the first NGS solution that can simultaneously profile all relevant myeloid DNA mutations and RNA fusion transcripts and deliver results in a single day.

We will also feature our latest immune repertoire assays for sequencing the B-cell and T-cell immunoglobulin receptors. These solutions offer breakthrough capabilities for assessing clonality and detecting rare clones in lymphoid neoplasm samples.

Scientific Poster Session

Characterization of immunoglobulin heavy- and light-chain repertoires in a single reaction

December 6, 2020

Cropped- Image

Geoffrey Lowman, PhD

Senior Staff Scientist - Molecular Biology, Clinical Next-Generation Sequencing

Thermo Fisher Scientific

See how we can help simplify the workflow for clonality assessment and rare clone detection in B-cell malignancy research. Our new assays can profile B-cell receptor heavy and light chains in a single library reaction, allowing for a higher success rate in clonality detection while maintaining the ability to detect rare clones (down to 1:10⁶).

Featured Product: The Oncomine Myeloid Assay GX

Experience A New Paradigm for Myeloid Profiling

1-Day Genomic Profiling For Myeloid Malignancy Research

With the Ion Torrent Oncomine Myeloid Assay GX on the Ion Torrent Genexus System, you can get a comprehensive myeloid mutational profile from a single next-generation sequencing (NGS) run and results in just one day. A highly integrated workflow lets you go from specimen to report with only 10 minutes of hands-on time and two user touch points*. It’s never been easier to implement myeloid NGS testing in your lab.

Oncomine-Myeloid-Assay-Flyer-Final_2

Oncomine Myeloid Assay GX Flyer

Screen Shot 2020-06-21 at 1.51.20 PM

Oncomine Myeloid Assay GX Infographic

For Research Use Only. Not for use in diagnostic procedures. *Specimen-to-report workflow will be available after the Ion Torrent Genexus Purification System and integrated reporting capabilities are added in 2021 with the Genexus 6.4 software upgrade.